GLICLAZID MR Sandoz cpr ret 60 mg 90 pce
7680659670026
CH-65967
A10BB09
07.06.2.
Reimbursement limitations:
DIAMICRON
Pris en charge lorsque la metformine ne permet pas un contrôle suffisant de la glycémie.
…
1 / 3
google
Details
- Product number
- 6596701
- CPT
- -
- Packaging group
- 90
- Unit
- Tablette(n)
- Composition
- gliclazidum 60.00 mg, calcii hydrogenophosphas dihydricus, povidonum K 30, hypromellosum, magnesii stearas, excipiens pro compresso.
Articles (1)
Gliclazid MR Sandoz 60mg, Retardtabletten
Tabletten
90
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 37.35
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2017
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 65967
- Drug name
- Gliclazid MR Sandoz, Retardtabletten
- Galenic form
- RETT
- ATC Code
- A10BB09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 17/11/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GLICLAZID MR Sandoz cpr ret 60 mg 90 pce
- Description (DE)
- GLICLAZID MR Sandoz Ret Tabl 60 mg 90 Stk
- Market launch
- 17/11/2016
- Narcotic (BTM)
- No